Amplitude Healthcare Acquisition Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMHC research report →
Price Chart
About the company
Amplitude Healthcare Acquisition Corporation currently does not conduct extensive business operations. Its core strategy involves acquiring enterprises or their assets within the healthcare or related sectors. This will be accomplished via various corporate actions, including mergers, stock exchanges, share acquisitions, restructuring efforts, or similar business consolidations.
- CEO
- Balaji Venkataraman
- IPO
- 2019
- Employees
- 1
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on AMHC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.12B
- P/E
- -10.88
- PEG
- -0.04
- P/S
- 0.00
- P/B
- 207.76
- EV/EBITDA
- 3347.35
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-83,883,000
- Net Income
- $0+0.0%
- EPS
- $-3.95+19.2%
- OCF Growth
- -23.3%
- FCF Growth
- -22.2%
- 52W High
- $15.80
- 52W Low
- $9.80
- 50D MA
- $10.32
- 200D MA
- $10.01
- Beta
- 0.00
- RSI (14)
- 93
- Avg Volume
- 263.45K
No earnings-call transcripts are available for AMHC yet.
- Free Float
- 55.8%
- Shares Outstanding
- 109.32M
- Float Shares
- 60.95M
of shares held by institutions
59 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Context Partners Fund, L.P. | 50.00K | ▲ 50.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 21, 21 | GLAZER CAPITAL, LLC | sell | 1,164 |
| Apr 23, 21 | GLAZER CAPITAL, LLC | sell | 151,719 |
| Apr 19, 21 | GLAZER CAPITAL, LLC | sell | 2,060 |
| Feb 18, 21 | GLAZER CAPITAL, LLC | sell | 10,000 |
| Feb 19, 21 | GLAZER CAPITAL, LLC | sell | 2,112 |
| Feb 22, 21 | GLAZER CAPITAL, LLC | sell | 698 |
| Feb 5, 21 | GLAZER CAPITAL, LLC | sell | 212 |
| Jan 14, 21 | GLAZER CAPITAL, LLC | sell | 101 |
| Jan 8, 21 | GLAZER CAPITAL, LLC | sell | 10,000 |
| Dec 29, 20 | GLAZER CAPITAL, LLC | sell | 18 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMHC coverage
Recent articles, reports, and earnings notes.
No research on AMHC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMHC report →Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy
businesswire.com · Sep 24
AMHC Stock: Why It Substantially Increased Today
pulse2.com · Sep 23
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Amplitude Healthcare Acquisition Corp. - AMHC
prnewswire.com · Jun 8
'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines
benzinga.com · May 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.